Health Care & Life Sciences » Pharmaceuticals | Wakamoto Pharmaceutical Co. Ltd.

Wakamoto Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
1,359
232
126
170
174
230
Depreciation, Depletion & Amortization
710
767
746
659
527
468
Other Funds
806
425
41
65
247
264
Funds from Operations
1,262
1,423
914
764
454
26
Changes in Working Capital
367
248
319
334
101
89
Net Operating Cash Flow
1,629
1,175
594
1,098
556
114
Capital Expenditures
737
1,240
483
349
426
Sale of Fixed Assets & Businesses
-
1
-
1
295
Purchase/Sale of Investments
205
30
152
75
379
Net Investing Cash Flow
942
1,270
329
22
47
Cash Dividends Paid - Total
1
104
104
104
104
Issuance/Reduction of Debt, Net
232
206
209
331
163
Net Financing Cash Flow
239
314
316
437
271
Net Change in Cash
448
409
51
683
238
Free Cash Flow
929
34
180
764
236
Change in Capital Stock
6
5
3
2
4
Miscellaneous Funds
-
-
-
-
-

About Wakamoto Pharmaceutical Co.

View Profile
Address
2-2-2 Nihonbashi Hon-cho
Tokyo Tokyo 103
Japan
Employees -
Website http://www.wakamoto-pharm.co.jp
Updated 07/08/2019
Wakamoto Pharmaceutical Co., Ltd. engages in the manufacture and sale of ethical and non-prescription drugs. Its operations are carried out through the following segments: Medicine, Non-Prescription Drugs, Special Sales and Others. The Medicine segment provides ethical drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.